Your doctor may advise you to try betahistine for 6 to 12 months to see if it helps to reduce your symptoms. If it does, it can then be continued.
Betahistine comes as 8mg or 16mg tablets. The usual starting dose is 16mg, taken 3 times a day. Leave 6 to 8 hours between doses. When your symptoms are under control, your doctor may reduce your dose to 8mg, taken 3 times a day.
You'll usually take betahistine 3 times a day, leaving 6 to 8 hours between doses. When you start taking betahistine it may take a couple of weeks before you notice any improvements.
Are there any long-term side effects? Betahistine is unlikely to do you any harm, even if you take it for a long time. It's generally a very safe medicine.
Betahistine is effective in improving vertigo-associated symptoms, with longer treatment periods leading to greater improvements; however, it is not known whether these effects persist after treatment cessation.
Do not stop taking this medicine suddenly, or change the dosage, without checking with your doctor. Do not use this medicine to treat any other complaints unless your doctor or pharmacist tells you to. Do not give this medicine to anyone else, even if they have the same condition as you.
Anxiety symptoms
The repeated-measures ANOVA showed a significant effect of time (P<0.00001), indicating that both high-dose and low-dose betahistine could significantly reduce the HARS score.
Betahistine minimises the nerve signals which are sent from the inner ear to the brain and helps to relieve such symptoms of Meniere's disease.
Taking the drug betahistine could reduce the feeling of vertigo, even when the cause hasn't been found. Vertigo is a feeling that the environment is moving around when it is not. It can be caused by problems in the ear or the brain.
Some medicines and betahistine affect each other and can increase your chance of side effects. Tell your pharmacist or doctor if you're taking: medicines called MAO inhibitors, used to treat depression or Parkinson's disease. antihistamines for allergies such as hay fever.
Conclusion: Betahistine prevented PTZ-induced memory loss; an effect could be in part attributed to the enhanced cholinergic activity and GSK3-β inhibition.
Medication can be used to treat episodes of vertigo caused by vestibular neuronitis or Ménière's disease. It may also be used for central vertigo or vertigo with an unknown cause. The medicines are usually prescribed for 3 to 14 days, depending on which condition they're for.
Medicinal Benefits
BETAHISTINE is indicated to treat symptoms such as ringing in your ears (tinnitus), dizziness, vertigo, loss of balance, and hearing loss associated with Meniere's disease. BETAHISTINE works by increasing the blood flow to your brain and by lowering the extra pressure build up in the inner ear.
Betahistine in a dose of 16 mg three times daily is an effective antivertigo therapy, which improves blood perfusion to ischaemic areas of the brain.
Few studies had compared the effect of betahistine and metformin before. According to our study, although betahistine group failed to decrease the body weight significantly, it prevented further weight gain with a decreasing tendency.
Stomach upsets can be overcome by taking Betahistine Sandoz during meals. Tell your doctor as soon as possible if you notice any of the following: skin reactions • difficulty breathing • convulsions • hallucinations • confusion • allergic reaction • low blood pressure, slow heart beat These may be serious side effects.
If you take more Betahistine than you should
If you accidentally take too many tablets, contact your doctor or nearest hospital emergency department immediately for advice. Remember to take this leaflet or any remaining tablets with you.
Stomach upset, nausea, and headache may occur. This medication may also rarely cause drowsiness.
Curiously, Serc was approved by the US FDA about 50 years ago for roughly 5 years, but later approval was withdrawn because lack of evidence for efficacy and because "the major report of effectiveness contained deficiencies and misrepresentations" (Sampson, 2003).
It has been suggested that betahistine hydrochloride reduces the frequency and severity of vertiginous episodes and tinnitus and arrests the progression of hearing loss in patients with Ménière's syndrome (Solvay 1998).
Betahistine therapy was also accompanied by progressive improvements in mean Hospital Anxiety and Depression anxiety and depression scores (P<0.0001) and significant improvements in both the physical and mental component summary of the SF-36v2 (P<0.0001).
Eye irritation and palpitations were more commonly reported with high dose betahistine than with low dose betahistine and placebo. Differences were, however, small and probably not clinically relevant.
Antihistamines, e.g. betahistine and cinnarizine. These are sedative, and patients should not operate machinery or drink alcohol.